At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 134 enrolled
Drug / intervention
Pre-urodynamic Levofloxacin +1 moredrug
Likely dose
Pre-urodynamic Levofloxacin 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of the Effectiveness of Preurodynamic Single Dose of Levofloxacin With Posturodynamic Levofloxacin for Three Days on the Incidence of Urinary Tract Infections
In Brief
A Phase 2 clinical trial evaluating Pre-urodynamic Levofloxacin and Post-urodynamic Levofloxacin for Urinary Tract Infections. Completed, enrolled 134 participants across 1 site.
Detailed Summary
This study aims to compare the effectiveness of preoperative single dose of levofloxacin with postoperative levofloxacin for three days on the incidence of urinary tract infections (UTI) after urodynamic examination.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUrinary Tract Infections
CountriesIndonesia
Collaborators--
Timeline
Phase 2CompletedFinished
20222023202420252026
First PostedFeb 2022
Enrollment StartFeb 2022
Primary CompletionApr 2022
Study CompletionApr 2022
TodayJul 2026
First PostedFeb 2, 2022
Enrollment StartFeb 4, 2022
Primary CompletionApr 3, 2022
Study CompletionApr 13, 2022
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 4.4 years ago
Interventions
Pre-urodynamic Levofloxacindrug
Levofloxacin 500 mg single dosage 1 hour before the urodynamic examination
Post-urodynamic Levofloxacindrug
Administering once daily Levofloxacin 500 mg for 3 days after urodynamic study